Package Leaflet: Information for the User
Rivaroxaban Bayer 15mg + 20mg film-coated tablets EFG
Starter Pack for Treatment Initiation
Not for use in children.
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
Contents of the Package Leaflet
This medication contains the active substance rivaroxaban and is used in adults to:
This medication belongs to a group of medications called antithrombotic agents. It works by blocking a clotting factor (factor Xa) and thus reducing the tendency of blood to form clots.
Do not takeRivaroxaban Bayer
Do not take this medication and inform your doctorif any of these circumstances apply to you.
Warnings and precautions
Consult your doctor or pharmacist before starting to take this medication.
Be particularly careful with Rivaroxaban Bayer
Tell your doctorif you have any of these situationsbefore taking this medication. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If you need surgery:
Children and adolescents
The starter pack for Rivaroxaban Bayer treatment is not recommended for persons under 18 years of age, as it is specifically designed for treatment initiation in adult patients and is not suitable for use in children and adolescents.
Other medications and Rivaroxaban Bayer
Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medication, including those purchased without a prescription.
If any of the above circumstances apply to you, tell your doctorbefore taking this medication, as the effect of this medication may be increased. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
If your doctor considers that you have a higher risk of developing a stomach or intestinal ulcer, they may recommend that you also use a preventive treatment.
If any of the above circumstances apply to you,tell your doctorbefore taking this medication, as the effect of this medication may be reduced. Your doctor will decide if you should be treated with this medication and if you should be kept under closer observation.
Pregnancy and breastfeeding
Do not take this medication if you are pregnant or breastfeeding. If there is any possibility that you may become pregnant, use a reliable contraceptive while taking this medication. If you become pregnant while taking this medication, tell your doctor immediately, who will decide how you should be treated.
Driving and using machines
This medication may cause dizziness (a frequent side effect) or fainting (a rare side effect) (see section 4 "Possible side effects"). You should not drive, ride a bicycle, or use tools or machines if you are affected by these symptoms.
Rivaroxaban Bayercontains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
This medication contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow your doctor's instructions for taking this medication exactly. If you are unsure, consult your doctor or pharmacist again.
You must take this medication with food.
Swallow the tablets, preferably with water.
If you have difficulty swallowing the tablet whole, consult your doctor about other ways to take this medication. The tablet can be crushed and mixed with water or apple sauce, immediately before taking it. Then, take food.
If necessary, your doctor may also administer the crushed rivaroxaban tablet through a gastric tube.
What dose to take
The recommended dose is one 15 mg rivaroxaban tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the recommended dose is one 20 mg rivaroxaban tablet once a day.
This starter pack for rivaroxaban 15 mg and 20 mg is only for the first 4 weeks of treatment.
Once this pack is finished, treatment will continue with rivaroxaban 20 mg once a day, as indicated by your doctor.
If you have kidney problems, your doctor may decide to reduce your treatment dose to one 15 mg rivaroxaban tablet once a day after 3 weeks if the risk of bleeding is higher than the risk of having another blood clot.
When to take Rivaroxaban Bayer
Take the tablets every day, until your doctor tells you to stop.
Try to take the tablets at the same time every day to remember when to take them.
Your doctor will decide how long you should continue taking the treatment.
If you take more Rivaroxaban Bayer than you should
Call your doctor immediately if you have taken too many rivaroxaban tablets. Taking too much rivaroxaban increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Rivaroxaban Bayer
If you stop taking Rivaroxaban Bayer
Do not stop taking this medication without consulting your doctor first, as this medication treats and prevents serious conditions.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them.
Like other similar medications to reduce blood clot formation, this medication can cause bleeding that can put the patient's life at risk. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be apparent.
Tell your doctor immediately if you experience any of the following symptoms:
Your doctor may decide to keep you under closer observation or change your treatment.
The frequency of these side effects is very rare (up to 1 in 10,000 people).
The frequency of severe allergic reactions is very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible side effects
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(frequency cannot be estimated from available data)
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are possible side effects not listed in this package leaflet. You can also report them directly through the Spanish Medication Monitoring System for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on each blister after “EXP”.
The expiry date is the last day of the month indicated.
No special storage conditions are required.
Crushed tablets
Crushed tablets are stable in water or apple puree for up to 4 hours.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the pharmacy's SIGRE collection point. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition ofRivaroxabán Bayer
Tablet core: microcrystalline cellulose, sodium croscarmellose, lactose monohydrate, hypromellose, sodium lauryl sulfate, magnesium stearate. See section 2 “Rivaroxabán Bayer contains lactose and sodium”.
Tablet film coating: macrogol, hypromellose, titanium dioxide (E 171), red iron oxide (E 172).
Appearance and package contents of the product
Rivaroxabán Bayer 15 mg film-coated tablets are round, red, biconvex, and bear the Bayer cross on one side and “15” and a triangle on the other.
Rivaroxabán Bayer 20 mg film-coated tablets are round, reddish-brown, biconvex, and bear the Bayer cross on one side and “20” and a triangle on the other.
Package for initial treatment in the first 4 weeks: each package of 49 film-coated tablets for initial treatment in the first 4 weeks contains:
42 film-coated tablets of 15 mg rivaroxaban and 7 film-coated tablets of 20 mg rivaroxaban in a calendar package.
Marketing authorization holder and manufacturer
Marketing authorization holder
Bayer Hispania, S.L.
Av. Baix Llobregat, 3-5
08970 Sant Joan Despí (Barcelona)
Spain
Manufacturer
The manufacturer can be identified by the batch number printed on the side flap of the carton and on each blister:
Bayer AG
Kaiser-Wilhelm-Allee
51368 Leverkusen
Germany
Bayer HealthCare Manufacturing Srl.
Via delle Groane, 126
20024 Garbagnate Milanese
Italy
Bayer Bitterfeld GmbH
Ortsteil Greppin, Salegaster Chaussee 1
06803 Bitterfeld-Wolfen
Germany
This medicine is authorized in the Member States of the European Economic Area under the following names:
Germany, Denmark, Spain, Sweden: Rivaroxaban Bayer
Austria: Rivaroxaban Bayer Starterpackung 15 mg + 20 mg Filmtabletten
Date of last revision of this leaflet:08/2023.
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).